Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in TENX — Tenax Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to TENX Full portfolio

Position in TENX

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$10,600,562
+$8,161,833 QoQ
Shares Held
728,561
+377.7% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 111 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TENX Over Time

Shares Held

Position Value (USD)

Derivatives in TENX

reported options exposure · as of Jun 30, 2026
CallValue
$1,897,320
CallShares
130,400
PutValue
$531,075
PutShares
36,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. TENX ranks #95 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in TENX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $531,075 36,500
2026-06-30 $1,897,320 130,400
2026-06-30 $10,600,562 728,561
2026-03-31 $2,438,729 152,516
2025-12-31 $1,578,945 129,528
2025-09-30 $329,154 43,253
2025-06-30 $59,587 10,345
2025-03-31 $151,573 23,141
2023-12-31 $13,902 50,556
2023-09-30 $4,494 15,033